DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 128 participants.
Also called NCT06657833
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 128 participants
- Sponsor
- Registry
-
NCT06657833
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Netherlands, Spain
- Registry status
- Recruiting
Technical summary
Registry record NCT06657833. Randomized; no masking; primary purpose treatment. Start 2024-12-17 (actual); primary completion 2027-10-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.
- Acronym
- DEBSCAN-IVL
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Percutaneous coronary intervention of a calcified nodule with intravascular lithotripsy followed by drug eluting balloon
- Intervention (Device)
- Percutaneous coronary intervention of a calcified nodule with intravascular lithotripsy followed by drug eluting stent
- Lead sponsor
- Fundación EPIC
Record details
- Record id
cardio:ct-nct06657833- Content hash
8dca378423c8c0cf03536bfb87eef34e755a5abec1827eb06c05e191038ee098